Cambridge Enterprise launches new initiative to boost Cambridge startups’ access to tech’s biggest global markets
University city ranked behind only the Bay Area and Boston, in Dealroom's latest ranking of global innovation ecosystems.
Cambridge Enterprise recognised as a World Class employer and one of the Best Companies to Work For in the UK
Cambridge Enterprise places Top Ten Best Company to Work for in the UK (Medium sized category) and awarded top Three Star accreditation in the 2025 Best Companies to Work For list
King’s Entrepreneurship Lab and Founders at the University of Cambridge’s SPARK 1.0 incubator reveal first cohort
From the College that gave the world Alan Turing, Geoff Hinton, Sydney Brenner, Fred Sanger and Hermann Hauser, a new incubator programme is unleashing the next generation of innovatorsCompanies range across software, AI, life sciences, sustainability and semiconductors From disease prevention and treatment, fertility and mental health care, companies are solving global challenges Cambridge, UK…
Cambridge Enterprise opens London hub to underline global ambition for university innovation
London, 26 June 2025: Cambridge Enterprise, the innovation arm of the University of Cambridge, is opening its first-ever London office in Kings Cross as it strengthens its position to compete on the global stage for capital and to propel more Cambridge innovations and research to commercial success with world-changing impact.
Founders at the University of Cambridge reveals 8 new deeptech startups powering growth through science
Predicting dementia AI, novel cancer therapies and new quantum chips: startups tackle hard problems as Founders at the University of Cambridge launches its second accelerator cohort.
Highlights from another great year for Cambridge Enterprise
The Cambridge Enterprise Annual Review 2024 showcases how the commercialisation of groundbreaking research creates tangible societal benefits.
Ceres Agri-Tech and the University of Lincoln showcase Agri-Tech Innovation in Parliament
Cambridge Enterprise initiative Ceres Agri-Tech and the University of Lincoln partner to showcase innovative agri-tech solutions from university science addressing global challenges
Cambridge Enterprise appoints new Chief Executive
Dr Jim Glasheen has been appointed as Chief Executive of Cambridge Enterprise, the innovation arm of the University of Cambridge. Dr Glasheen will assume his post later in 2024.
Cambridge Enterprise celebrates a year of innovation and economic growth
Cambridge Enterprise, the research commercialisation arm of the University of Cambridge, marked its 15th anniversary with a remarkable series of achievements.
Survey to gather insights on the long term innovation vision for Cambridge
Innovate Cambridge writes...As part of the Innovate Cambridge process, we would like to gather your insights and to do this we are launching two short surveys. These will provide an opportunity to highlight the issues that matter most to you and your organisation.
New grafting technique could combat the disease threatening Cavendish bananas
Scientists have found a novel way to combine two species of grass-like plant including banana, rice and wheat, using embryonic tissue from their seeds. The technique allows beneficial characteristics, such as disease resistance or stress tolerance, to be added to the plants.
Ceres Agri-Tech launches first three spin-outs
The first three spin-out companies have been launched from a government-backed knowledge exchange partnership designed to revolutionise the creation and uptake of early-stage agricultural technology (agri-tech) opportunities.
Cambridge Enterprise invests in Carbon Re, start-up cutting CO₂ emissions by gigatonnes
The University of Cambridge Enterprise Fund has joined in a £1 million investment in Carbon Re, a UK climate tech start-up that uses artificial intelligence to cut CO₂ emissions in the global cement industry and other hard-to-abate industrial processes. The investment will accelerate development of Carbon Re’s AI technology to help the global cement industry and other energy intensive industries…
University spin-out Echion Technologies raises £10m in Series A investment round
Funding will accelerate development of next-generation lithium-ion battery technology.
Semi-finalists announced in 2021 Chris Abell Postdoc Business Plan Competition
Thirteen semi-finalists have been announced for the 2021 Chris Abell Postdoc Business Plan Competition run by Cambridge Enterprise.
University of Cambridge appoints Dr Diarmuid O’Brien as new Chief Executive of Cambridge Enterprise
The University of Cambridge announces the appointment of Dr Diarmuid O’Brien as the new Chief Executive of Cambridge Enterprise, effective September 2021.
Cambridge spin-out HexagonFab secures £1.9m seed funding to launch the Bolt
University of Cambridge spin-out company HexagonFab today announced a £1.9 million seed funding round, led by Cambridge Enterprise, joined by Parkwalk, New Grounds VC, Silicon Valley-based R42 Group, and several private investors.
Cambridge spin-out SMAP Energy acquired by ENECHANGE
ENECHANGE has acquired 100% of share capital and acquisition rights in SMAP Energy, making the company a wholly owned subsidiary.
University spin-out Cambridge GaN Devices raises $9.5m in Series A investment round
Cambridge GaN Devices (CGD) has raised $9.5 million in Series A funding. The investment was co-led by IQ Capital, Parkwalk Advisors, and BGF and joined by Cambridge Enterprise, Foresight Williams, Martlet Capital, Cambridge Angels, and Cambridge Capital Group. CGD will use the funding to expand its product portfolio of energy-efficient power devices and to double the size of its team.
Three Cambridge spin-outs join Centessa Pharmaceuticals, launched with a $250m Series A round
ApcinteX, Morphogen-IX, Z Factor join seven other privately held biotech companies in a new type of pharmaceutical R&D model.
Cambridge launches eighth Enterprise fund
The University of Cambridge has launched its eighth Enterprise Fund, managed by university spinout fund manager Parkwalk in conjunction with Cambridge Enterprise, the University’s Technology Transfer Office.
Cambridge spin-out ApcinteX shares clinical trial results from its study of SerpinPC
ApcinteX Ltd, a biotech company spun out of the University of Cambridge, today announced the results from Part I of its ongoing clinical trial, AP-0101, assessing the safety, tolerability, and pharmacokinetics of its investigational drug SerpinPC in healthy volunteers and patients with severe haemophilia A and B.
GlycoVue wins the 2020 Cambridge Enterprise Postdoc Business Plan Competition
GlycoVue, which combines glucose-responsive smart polymers with advanced holography and AI-enabled smartphone technology for diabetes self-management, has won the £20,000 first prize in the 2020 Cambridge Enterprise Postdoc Business Plan Competition.
Psyomics secures £1.5m funding to transform mental health diagnosis in the UK
Psyomics Ltd, a UK-based healthtech and University of Cambridge spin-out, has closed a £1.5 million funding round from existing and new investors to bring its mental health assessment and diagnosis platform, Censeo, to market in the UK. University spinout specialists Parkwalk led the round, joined by fellow existing investors Jonathan Milner, Martlet, and Cambridge Enterprise.